TOPIC 9.2 EVALUATING INFLUENZA AND SARS-COV-2 VACCINE EFFECTIVENESS AGAINST OUTPATIENT, LABORATORY-CONFIRME…

Award details are derived from public USAspending.gov records. Not a bid recommendation.

Award details

Award ID: 75D30121C11909
Contractor
Awarding agency: Department of Health and Human Services
Sub-agency / office: Centers for Disease Control and Prevention
Award amount: $1,200,000
Period of performance: Sep 30, 2021 – Jul 31, 2022
NAICS: 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC: PSC AN11
Place of performance: CA

TOPIC 9.2 EVALUATING INFLUENZA AND SARS-COV-2 VACCINE EFFECTIVENESS AGAINST OUTPATIENT, LABORATORY-CONFIRMED ILLNESS

Discover comparable awards, related contractors, and agency purchasing history.

Same agency and NAICS · 75F40126F80199 — TARGETED OPERATIONS ASSESSMENT SUPPORT · Department of Health and Human Services · $3,249,000
Same agency and NAICS · 75N91026F00028 — 126797 CAMPUS REPLACE BSCS · LEIDOS BIOMEDICAL RESEARCH INC · Department of Health and Human Services · $1,912,753
Same agency and NAICS · 75N98026F00413 — NIH LITGRAPH PROTOTYPE DEVELOPMENT · Department of Health and Human Services · $1,308,185
Same agency and NAICS · 75F40126C00154 — EO 14398 - (BAA# FY26C1CP17) RELEASE MECHANISMS OF ORAL MR PRODUCTS: DISSOLUTION METHOD DEVELOPMENT AND MEC… · Department of Health and Human Services · $599,999
Same NAICS · FA945322C0011 — ASSURED SPACE-BASED PNT INNOVATION, RESEARCH & EXPERIMENT (ASPIRE) R&D PROGRAM. IN ACCORDANCE WITH: 10 USC… · CANYON CONSULTING, LLC · Department of Defense · $31,523,489
Same NAICS · FA865022F5408 — MATERIALS RESEARCH AND SURVIVABILITY STUDIES (MARSS) II- INCREMENTAL FUNDING · AZIMUTH CORPORATION · Department of Defense · $19,955,108